Aspen Aerogels, Inc. (NYSE:ASPN) reported Q2 2017 earnings this Afternoon, coming in at ($0.23) per share, beating Wall Street’s estimates of ($0.24) per Share. Revenue for the quarter came in at $25.10 million beating analyst estimates of $24.79 million
Analyst Coverage For Aspen Aerogels, Inc. (NYSE:ASPN)
These are 3 Hold Ratings, 3 Buy Ratings .
The current consensus rating for Aspen Aerogels, Inc. (NYSE:ASPN) is Buy (Score: 2.50) with a consensus target price of $7.25 , a potential (57.27% upside)Recent Insider Trading for Aspen Aerogels, Inc. (NYSE:ASPN)
- On 5/5/2017 Robert M Gervis, Director, bought 1,400 with an average share price of $4.00 per share and the total transaction amounting to $5,600.00.
- On 5/4/2017 Robert M Gervis, Director, bought 791 with an average share price of $4.00 per share and the total transaction amounting to $3,164.00.
- On 5/1/2017 Robert M Gervis, Director, bought 250 with an average share price of $4.00 per share and the total transaction amounting to $1,000.00.
- On 4/26/2017 Robert M Gervis, Director, bought 6,305 with an average share price of $4.00 per share and the total transaction amounting to $25,220.00.
- On 4/25/2017 Robert M Gervis, Director, bought 800 with an average share price of $4.00 per share and the total transaction amounting to $3,200.00.
- On 4/24/2017 Robert M Gervis, Director, bought 18,201 with an average share price of $4.00 per share and the total transaction amounting to $72,804.00.
Recent Trading for Aspen Aerogels, Inc. (NYSE:ASPN) Shares of Aspen Aerogels, Inc. closed the previous trading session at 4.61 up +0.05 1.10% with 66,681 shares trading hands.